Evidence map›Paper›PMID 33694036›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation.

Sarah Soueges, Claire Triffault-Fillit, Sandrine Roux, Hélène Labussière-Wallet, David Lebeaux, Oana Dumitrescu, Isabelle Morelec, Elisabeth Hodille, Florence Ader, Lyon HEMINF study group

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Nocardia antimicrobial susceptibility testing by microdilution: evaluation of ready-to-use plate including tedizolid and meropenem.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sarah SouegesDépartement des Maladies infectieuses et tropicales, Hospices Civils de Lyon, F-69004, Lyon, France.
Claire Triffault-FillitDépartement des Maladies infectieuses et tropicales, Hospices Civils de Lyon, F-69004, Lyon, France.
Sandrine RouxDépartement des Maladies infectieuses et tropicales, Hospices Civils de Lyon, F-69004, Lyon, France.
Hélène Labussière-WalletDépartement d'Hématologie clinique, Hospices Civils de Lyon, F-69495, Pierre-Bénite, France.
David LebeauxUniversité de Paris, 75006, Paris, France.
Oana DumitrescuCentre International de Recherche en Infectiologie (CIRI), Inserm 1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Univ Lyon, F-69007, Lyon, France.
Isabelle MorelecDépartement de médecine nucléaire, Hospices Civils de Lyon, F-69495, Pierre-Bénite, France.
Elisabeth HodilleInstitut des Agents Infectieux, Hospices Civils de Lyon, F-69004, Lyon, France.
Florence AderDépartement des Maladies infectieuses et tropicales, Hospices Civils de Lyon, F-69004, Lyon, France. florence.ader@chu-lyon.fr.
Lyon HEMINF study group
Hospices Civils de Lyon · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nocardiosis is a life-threatening opportunistic infection in immunocompromised patients. Herein, we present successful adjunctive use of liposomal nebulized amikacin and tedizolid in a recipient of allogeneic hematopoietic stem cell transplantation infected with Nocardia nova complex who presented multiple complications to conventional therapeutic options.

Indexed as

AmikacinAnti-Bacterial AgentsHematopoietic Stem Cell TransplantationHumansImmunosuppressive AgentsLiposomesMaleMiddle AgedNebulizers and VaporizersNocardiaNocardia InfectionsOxazolidinonesTetrazolesTime FactorsAmikacinAnti-Bacterial AgentsImmunosuppressive AgentsLiposomesOxazolidinonestedizolidTetrazolesAllogeneic hematopoietic stem cell transplantationLiposomal nebulized amikacinNocardiosisTedizolid

Identifiers

PMID33694036
OpenAlexW3134776078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.